{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:29:54Z","timestamp":1794050994562,"version":"4.8.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T00:00:00Z","timestamp":1780185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100010344","name":"Aage og Johanne Louis-Hansens Fond","doi-asserted-by":"publisher","award":["24-2B-14771"],"award-info":[{"award-number":["24-2B-14771"]}],"id":[{"id":"10.13039\/501100010344","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010344","name":"Aage og Johanne Louis-Hansens Fond","doi-asserted-by":"publisher","award":["2024-0181"],"award-info":[{"award-number":["2024-0181"]}],"id":[{"id":"10.13039\/501100010344","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic opioid use (COU) is frequent in inflammatory bowel disease (IBD), but data on its association with infections and mortality are scarce. We examined (1) hospital-diagnosed infections, (2) prescribed systemic antibiotic\/antiviral\/antifungal agents, and 3) death associated with COU, and assessed these outcomes according to opioid strength.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This nationwide cohort study included all prevalent adult patients with Crohn disease (CD) and ulcerative colitis (UC) in Denmark from January 1, 2000, to June 30, 2023. Chronic opioid use (COU) was a time-varying exposure (\u22653 opioid prescriptions within 12\u2009months, with\u2009\u2265\u200930\u2009days between each prescription). Cox regression models were used to estimate adjusted hazard ratios (aHRs), including baseline and time-varying covariates (IBD surgery, IBD medications, and psychotropic medications).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We included 18\u200a897 patients with CD, of whom 3948 (20.9%) had COU. Among those with COU, the aHRs for hospital-diagnosed infections, prescribed antibiotics, and death were 1.91 (95% CI, 1.79-2.04), 1.47 (95% CI, 1.40-1.56), and 1.76 (95% CI, 1.58-1.96), respectively. We included 32\u200a947 patients with UC, of whom 4779 (14.5%) had COU. Among those with COU, the aHRs for hospital-diagnosed infections, prescribed antibiotics, and death were 1.93 (95% CI, 1.80-2.06), 1.56 (95% CI, 1.47-1.65), and 1.74 (95% CI, 1.60-1.90), respectively. Both strong and weak opioids were associated with these adverse outcomes in CD and UC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Real-world data have demonstrated an association between COU and increased risks of infections and mortality, independent of opioid strength, affecting users of both strong and weak opioids. Clinicians should be attentive to these risks when prescribing opioids to this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izag085","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:46:27Z","timestamp":1776858387000},"page":"1919-1927","source":"Crossref","is-referenced-by-count":0,"title":["Chronic opioid use and the risk of infections and death in patients with inflammatory bowel disease: a nationwide cohort study based on real-world data"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9514-3033","authenticated-orcid":false,"given":"Bente Mertz","family":"N\u00f8rg\u00e5rd","sequence":"first","affiliation":[{"name":"Center for Clinical Epidemiology, Odense University Hospital , Odense C 5000,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , 5000 Odense C,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1110-6614","authenticated-orcid":false,"given":"Kevin Erichsen","family":"Zeiss","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology, Odense University Hospital , Odense C 5000,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , 5000 Odense C,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-8441","authenticated-orcid":false,"given":"Rahul S","family":"Dalal","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School , 02115 Boston, MA,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3959-2926","authenticated-orcid":false,"given":"Ken","family":"Lund","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology, Odense University Hospital , Odense C 5000,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , 5000 Odense C,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4598-8679","authenticated-orcid":false,"given":"Mette Louise","family":"Andersen","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology, Odense University Hospital , Odense C 5000,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , 5000 Odense C,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8148-6572","authenticated-orcid":false,"given":"Jens","family":"Kjeldsen","sequence":"additional","affiliation":[{"name":"Department of Medical Gastrointestinal Diseases, Odense University Hospital , Odense C 5000,","place":["Denmark"]},{"name":"Research Unit of Medical Gastroenterology, Department of Clinical Research, University of Southern Denmark , Odense C 5000,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0726-0115","authenticated-orcid":false,"given":"Torben","family":"Knudsen","sequence":"additional","affiliation":[{"name":"Department of Medical Gastroenterology, Hospital of Southwest Jutland , 6700 Esbjerg,","place":["Denmark"]},{"name":"Department of Regional Health Science, University of Southern Denmark , 6700 Esbjerg,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7634-6812","authenticated-orcid":false,"given":"Jan","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Center for Clinical Epidemiology, Odense University Hospital , Odense C 5000,","place":["Denmark"]},{"name":"Research Unit of Clinical Epidemiology, Department of Clinical Research, University of Southern Denmark , 5000 Odense C,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,31]]},"reference":[{"key":"2026110706213560300_izag085-B1","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cgh.2020.08.041","article-title":"Opioid use among patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"19","author":"Niccum","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026110706213560300_izag085-B2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/apt.18014","article-title":"The use of opioids nine months after surgery for Crohn\u2019s disease - a nationwide cohort study","volume":"60","author":"Norgard","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"2026110706213560300_izag085-B3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.14309\/ajg.0000000000002497","article-title":"Older adult-onset of inflammatory bowel diseases is associated with higher utilization of analgesics: a nationwide cohort study","volume":"119","author":"Dalal","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"2026110706213560300_izag085-B4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/apt.15023","article-title":"Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids","volume":"49","author":"Noureldin","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2026110706213560300_izag085-B5","doi-asserted-by":"publisher","first-page":"e0156666","DOI":"10.1371\/journal.pone.0156666","article-title":"Pain in IBD patients: very frequent and frequently insufficiently taken into account","volume":"11","author":"Zeitz","year":"2016","journal-title":"PLoS One"},{"key":"2026110706213560300_izag085-B6","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.14309\/ajg.0000000000003353","article-title":"Predictors for chronic opioid use in patients with inflammatory bowel disease: a population-based cohort study","volume":"120","author":"Norgard","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"2026110706213560300_izag085-B7","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/ajg.2014.230","article-title":"The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis","volume":"109","author":"Targownik","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"2026110706213560300_izag085-B8","article-title":"The association between non-steroidal anti-inflammatory drug use and inflammatory bowel disease exacerbations: a true association or residual bias?","author":"Shirley","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"2026110706213560300_izag085-B9","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154269","article-title":"Abdominal pain in inflammatory bowel diseases: a clinical challenge","volume":"11","author":"Wils","year":"2022","journal-title":"J Clin Med"},{"key":"2026110706213560300_izag085-B10","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.cgh.2019.12.024","article-title":"Exposure to intravenous opioids is associated with future exposure to opioids in hospitalized patients with inflammatory bowel diseases","volume":"18","author":"Dalal","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026110706213560300_izag085-B11","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1097\/MCG.0b013e31821fbd82","article-title":"Understanding and treating abdominal pain and spasms in organic gastrointestinal diseases: inflammatory bowel disease and biliary diseases","volume":"45(suppl)","author":"Makharia","year":"2011","journal-title":"J Clin Gastroenterol."},{"key":"2026110706213560300_izag085-B12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2017.10.022","article-title":"Increasing prescription of opiates and mortality in patients with inflammatory bowel diseases in England","volume":"16","author":"Burr","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026110706213560300_izag085-B13","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/ajg.2012.218","article-title":"Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry","volume":"107","author":"Lichtenstein","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2026110706213560300_izag085-B14","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1093\/cid\/ciy809","article-title":"Long-acting opioid use and the risk of serious infections: a retrospective cohort study","volume":"68","author":"Wiese","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026110706213560300_izag085-B15","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/bph.13750","article-title":"Opioids and the immune system - friend or foe","volume":"175","author":"Plein","year":"2018","journal-title":"Br J Pharmacol"},{"key":"2026110706213560300_izag085-B16","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.2174\/138161212803582496","article-title":"Non-analgesic effects of opioids: mechanisms and potential clinical relevance of opioid-induced immunodepression","volume":"18","author":"Sacerdote","year":"2012","journal-title":"Curr Pharm Des"},{"key":"2026110706213560300_izag085-B17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/SPC.0b013e3282f5272e","article-title":"Opioid-induced immunosuppression","volume":"2","author":"Sacerdote","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"key":"2026110706213560300_izag085-B18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11481-011-9290-7","article-title":"Immunosuppressive effects of opioids\u2014clinical relevance","volume":"6","author":"Brack","year":"2011","journal-title":"J Neuroimmune Pharmacol"},{"key":"2026110706213560300_izag085-B19","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2217\/fmb-2018-0101","article-title":"The use of prescribed opioid analgesics & the risk of serious infections","volume":"13","author":"Wiese","year":"2018","journal-title":"Future Microbiol"},{"key":"2026110706213560300_izag085-B20","doi-asserted-by":"publisher","first-page":"dyw213","DOI":"10.1093\/ije\/dyw213","article-title":"Data resource profile: the Danish national prescription registry","volume":"46","author":"Potteg\u00e5rd","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2026110706213560300_izag085-B21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"2026110706213560300_izag085-B22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"2026110706213560300_izag085-B23","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2147\/CLEP.S378003","article-title":"Validity of inflammatory bowel disease diagnoses in the danish national patient registry: a population-based study from the North Denmark Region","volume":"14","author":"Albaek Jacobsen","year":"2022","journal-title":"Clin Epidemiol"},{"key":"2026110706213560300_izag085-B24","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/ecco-jcc\/jjae047","article-title":"New surgery and hospital-diagnosed infections in elderly patients with inflammatory bowel disease undergoing surgery: a nationwide cohort study","volume":"18","author":"Norgard","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026110706213560300_izag085-B25","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1177\/13524585241249077","article-title":"Children born preterm or small for gestational age to mothers with multiple sclerosis: Do these children have an increased risk of infections in early life?","volume":"30","author":"Andersen","year":"2024","journal-title":"Mult Scler"},{"key":"2026110706213560300_izag085-B26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2026110706213560300_izag085-B27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2288-11-83","article-title":"The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients","volume":"11","author":"Thygesen","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"2026110706213560300_izag085-B28","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1097\/ALN.0000000000003265","article-title":"Persistent postoperative opioid use: a systematic literature search of definitions and population-based cohort study","volume":"132","author":"Jivraj","year":"2020","journal-title":"Anesthesiology"},{"key":"2026110706213560300_izag085-B29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1213\/ANE.0000000000003941","article-title":"American Society for enhanced recovery and perioperative quality initiative-4 joint consensus statement on persistent postoperative opioid use: definition, incidence, risk factors, and health care system initiatives","volume":"129","author":"Kent","year":"2019","journal-title":"Anesth Analg"},{"key":"2026110706213560300_izag085-B30","doi-asserted-by":"publisher","first-page":"e039238","DOI":"10.1136\/bmjopen-2020-039238","article-title":"Risk factors for new chronic opioid use after hip fracture surgery: a Danish nationwide cohort study from 2005 to 2016 using the Danish multidisciplinary hip fracture registry","volume":"11","author":"Edwards","year":"2021","journal-title":"BMJ Open"},{"key":"2026110706213560300_izag085-B31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1515\/sjpain-2019-0170","article-title":"The association between initial opioid type and long-term opioid use after hip fracture surgery in elderly opioid-naive patients","volume":"20","author":"Simoni","year":"2020","journal-title":"Scand J Pain"},{"key":"2026110706213560300_izag085-B32","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/ejp.1392","article-title":"Opioid use after hip fracture surgery: a Danish nationwide cohort study from 2005 to 2015","volume":"23","author":"Simoni","year":"2019","journal-title":"Eur J Pain"},{"key":"2026110706213560300_izag085-B33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/art.39462","article-title":"Opioid analgesics and the risk of serious infections among patients with rheumatoid arthritis: a self-controlled case series study","volume":"68","author":"Wiese","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026110706213560300_izag085-B34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.biopha.2006.06.015","article-title":"Pain management: is opioid immunosuppression a clinical problem?","volume":"60","author":"Budd","year":"2006","journal-title":"Biomed Pharmacother"},{"key":"2026110706213560300_izag085-B35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression: a review","volume":"11","author":"Vallejo","year":"2004","journal-title":"Am J Ther"},{"key":"2026110706213560300_izag085-B36","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1111\/j.1476-5381.2011.01475.x","article-title":"Depletion and recovery of lymphoid subsets following morphine administration","volume":"164","author":"Zhang","year":"2011","journal-title":"Br J Pharmacol"},{"key":"2026110706213560300_izag085-B37","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.4049\/jimmunol.180.5.3594","article-title":"Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling","volume":"180","author":"Wang","year":"2008","journal-title":"J Immunol"},{"key":"2026110706213560300_izag085-B38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11481-011-9303-6","article-title":"Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection","volume":"6","author":"Breslow","year":"2011","journal-title":"J Neuroimmune Pharmacol"},{"key":"2026110706213560300_izag085-B39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.pain.2004.04.020","article-title":"Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses","volume":"110","author":"Martucci","year":"2004","journal-title":"Pain"},{"key":"2026110706213560300_izag085-B40","doi-asserted-by":"publisher","first-page":"882","DOI":"10.4049\/jimmunol.0802763","article-title":"Mechanisms of opioid-mediated inhibition of human T cell receptor signaling","volume":"183","author":"Borner","year":"2009","journal-title":"J Immunol"},{"key":"2026110706213560300_izag085-B41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/joim.13124","article-title":"High incidence of healthcare facility-acquired Clostridium difficile infections in chronic opioid users","volume":"289","author":"Lichtbroun","year":"2021","journal-title":"J Intern Med"},{"key":"2026110706213560300_izag085-B42","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.3390\/biomedicines10081815","article-title":"Pain and opioid-induced gut microbial dysbiosis","volume":"10","author":"Thomas","year":"2022","journal-title":"Biomedicines"},{"key":"2026110706213560300_izag085-B43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/ADM.0000000000000928","article-title":"Trends in hospitalizations for serious infections among people with opioid use disorder in Ontario, Canada","volume":"16","author":"Gomes","year":"2022","journal-title":"J Addict Med"},{"key":"2026110706213560300_izag085-B44","doi-asserted-by":"publisher","first-page":"112739","DOI":"10.1016\/j.drugalcdep.2025.112739","article-title":"Rising opioid-associated skin and soft tissue infections and the emerging threat of xylazine: a national analysis","volume":"274","author":"Shah","year":"2025","journal-title":"Drug Alcohol Depend"},{"key":"2026110706213560300_izag085-B45","doi-asserted-by":"publisher","first-page":"e083791","DOI":"10.1136\/bmjopen-2023-083791","article-title":"Risk of infections among persons treated with opioids for chronic pain: a systematic review and meta-analysis protocol","volume":"14","author":"Kudrina","year":"2024","journal-title":"BMJ Open"},{"key":"2026110706213560300_izag085-B46","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.bja.2025.02.012","article-title":"Multimorbidity and analgesic-related harms: a systematic review","volume":"134","author":"Grant","year":"2025","journal-title":"Br J Anaesth"},{"key":"2026110706213560300_izag085-B47","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/CLEP.S37587","article-title":"Existing data sources for clinical epidemiology: the Danish National Database of Reimbursed Prescriptions","volume":"4","author":"Johannesdottir","year":"2012","journal-title":"Clin Epidemiol"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/10\/1919\/68439549\/izag085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/10\/1919\/68439549\/izag085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:21:42Z","timestamp":1794050502000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/10\/1919\/8698917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5,31]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izag085","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,5,31]]}}}